High Purity Survodutide BI 456906 Dual GLP-1 GCGR Agonist Lyophilized Peptide Powder 98%
TDS
2230198-02-2
Pharmaceutical Grade
99%
ShenZhen
XiWu
10mg/vial;10vials/box
2026-09-10
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferencePF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).Research & Reference Note
High Purity Survodutide BI 456906 Dual GLP-1 GCGR Agonist Lyophilized Peptide Powder 98% is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
CertificatesBasic Info-
Product Name:
2-[(4-{6-[(4-Cyano-2-fluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid
Other Name:PF-06882961;2230198-02-2;Danuglipron;UNII-DN9IUI24GP;DN9IUI24GP;2-[(4-{6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid;UK4;Danuglipron [USAN];CHEMBL4518483;SCHEMBL20266351
CAS No.:2230198-02-2
Molecular Formula:C31H30FN5O4
InChIKeys:HYBAKUMPISVZQP-DEOSSOPVSA-N
Exact Mass:555.22818262
UNII:DN9IUI24GP
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 307, No. 3, Building 7, Area 4, Pingchou, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
